206
T. Okitsu et al.
LETTER
Larock, R. C. J. Org. Chem. 2006, 71, 62. (k) Yao, T.;
Larock, R. C. J. Org. Chem. 2005, 70, 1432. (l) Yao, T.;
Campo, M. A.; Larock, R. C. J. Org. Chem. 2005, 70, 3511.
(m) Khan, Z. A.; Wirth, T. Org. Lett. 2009, 11, 229.
(3) Okitsu, T.; Nakazawa, D.; Taniguchi, R.; Wada, A. Org.
Lett. 2008, 10, 4967.
160 °C, to afford the cycloadduct 3 in 98% yield
(Scheme 4). Another advantage of our methodology is
that it accepts the C–C bond formation at the C–I bond by
Pd-catalyzed reactions. Thus, we were able to extend the
carbon-skeleton of 3 by either CsF-promoted Stille cou-
pling,11 or Sonogashira coupling, to provide 4a and 4b in
good yields. Three steps from 1m to 4a and 4b involve
dearomatizing iodocyclization, a domino DA reaction,
and a coupling reaction to achieve efficient molecular
transformations and allow the construction of a unique
bridgehead-spiro connection ring system.
(4) (a) Zhang, X.; Larock, R. C. J. Am. Chem. Soc. 2005, 127,
12230. (b) Tang, B.-X.; Tang, D.-J.; Tang, S.; Yu, Q.-F.;
Zhang, Y.-H.; Liang, Y.; Zhong, P.; Li, J.-H. Org. Lett.
2008, 10, 1063. (c) Yu, Q.-F.; Zhang, Y.-H.; Yin, Q.; Tang,
B.-X.; Tang, R.-Y.; Zhong, P.; Li, J.-H. J. Org. Chem. 2008,
73, 3658. (d) Tang, B.-X.; Yin, Q.; Tang, R.-Y.; Li, J.-H.
J. Org. Chem. 2008, 73, 9008. (e) Wang, Z.-Q.; Tang,
B.-X.; Zhang, H.-P.; Wang, F.; Li, J.-H. Synthesis 2009, 891.
(5) (a) Sakamoto, K.; Tsujii, E.; Abe, F.; Nakanishi, T.;
Yamashita, M.; Shigematsu, N.; Izumi, S.; Okuhara, M.
J. Antibiot. 1996, 49, 37. (b) Biard, J. F.; Guyot, S.;
Roussakis, C.; Verbist, J. F.; Vercauteren, J.; Weber, J. F.;
Boukef, K. Tetrahedron Lett. 1994, 35, 2691. (c) Imai, H.;
Suzuki, K.; Morioka, M.; Numasaki, Y.; Kadota, S.; Nagai,
K.; Sato, T.; Iwanami, M.; Saito, T. J. Antibiot. 1987, 40,
1475. (d) Bister, B.; Bischoff, D.; Ströbele, M.; Riedlinger,
J.; Reicke, A.; Wolter, F.; Bull, A. T.; Zähner, H.; Fiedler,
H.-P.; Süssmuth, R. D. Angew. Chem. Int. Ed. 2004, 43,
2574.
(6) General Procedure for ipso-Iodocyclization: To a solution
of 1a (51.0 mg, 0.150 mmol) in anhydrous CH2Cl2 (1.5 mL)
was added NIS (142 mg, 0.600 mmol) followed by BF3·OEt2
(74 mL, 0.600 mmol) at –40 °C. When the reaction was
complete, the mixture was diluted with sat. aq Na2S2O3 and
the mixture was extracted with CH2Cl2. The organic layer
was dried over Na2SO4, filtered, and evaporated in vacuo.
The residue was purified by flash column chromatography
on silica gel (hexane–EtOAc = 1:1) to give 2a (52.8 mg,
89%). N-Acetyl-3-iodo-4-phenyl-1-azaspiro[4,5]deca-
3,7,9-trien-6-one (2a): yellow amorphous solid. IR (CHCl3):
3017, 1676, 1655 cm–1. 1H NMR (500 MHz, CDCl3): d =
7.35–7.27 (3 H, m), 7.03–7.01 (2 H, m), 6.71 (ddd, J = 10.0,
4.5, 3.0 Hz, 1 H), 6.23–6.22 (m, 2 H), 6.01 (d, J = 9.5 Hz,
1 H), 4.78 (d, J = 13.5 Hz, 1 H), 4.61 (d, J = 13.5 Hz, 1 H),
2.12 (s, 3 H). 13C NMR (125 MHz, CDCl3): d = 197.2, 167.5,
145.9, 141.1, 138.9, 132.6, 128.9, 128.8, 128.0, 126.9,
123.5, 91.2, 77.7, 62.9, 21.8. HRMS (EI): m/z [M]+ calcd for
C17H14INO2: 391.0069; found: 391.0080.
In summary, we have constructed 1-aza-3-iodo-
spiro[4.5]deca-3,7,9-trien-6-ones through the ipso-iodo-
cyclization of ethoxyethyl ether to alkynes. When the
linker between the aromatic ring and the triple bond was
an ether or an ester, a domino reaction of ipso-iodo-
cyclization and DA reaction occurred. In addition, an oxa-
cyclic compound could be further functionalized by
domino retro-DA/DA reactions to construct a novel
bridgehead-spiro connection ring system. Further Pd-cat-
alyzed reactions escalated the molecular complexity and
diversity. This strategy may expand the scope of research
into bioactive compounds that are difficult to synthesize
by other methods. Determining the scope and limitations
of our synthetic methodology and further applications are
ongoing.
Acknowledgment
We thank Dr. Miyoko Kamigauchi for help with the recrystallizati-
on of 2m for X-ray crystallography. This work was supported in
part by a Grant-in-Aid for Encouragement of Young Scientists from
the Ministry of Education, Culture, Sports, Science and Technolo-
gy.
References and Notes
(1) For reviews, see: (a) Togo, H.; Iida, S. Synlett 2006, 2159.
(b) Larock, R. C. Acetylene Chem. 2005, 51. (c) French,
A. N.; Bissmire, S.; Wirth, T. Chem. Soc. Rev. 2004, 33, 354.
(2) For selected papers on the iodocyclizations of alkynes, see:
(a) Fischer, D.; Tomeba, H.; Pahadi, N. K.; Patil, N. T.;
Yamamoto, Y. Angew. Chem. Int. Ed. 2007, 46, 4764.
(b) Worlikar, S. A.; Kesharwani, T.; Yao, T.; Larock, R. C.
J. Org. Chem. 2007, 72, 1347. (c) Halim, R. H.; Scammells,
P. J.; Flynn, B. L. Org. Lett. 2008, 10, 1967. (d) Barluenga,
J.; Palomas, D.; Rubio, E.; González, J. M. Org. Lett. 2007,
9, 2823. (e) Garud, D. R.; Koketsu, M. Org. Lett. 2008, 10,
3319. (f) Bi, H.-P.; Guo, L.-N.; Duan, X.-H.; Gou, F.-R.;
Huang, S.-H.; Liu, X.-Y.; Liang, Y.-M. Org. Lett. 2007, 9,
397. (g) Barluenga, J.; Trincado, M.; Rubio, E.; González,
J. M. Angew. Chem. Int. Ed. 2006, 45, 3140. (h) Yue, D.;
Yao, T.; Larock, R. C. J. Org. Chem. 2005, 70, 10292.
(i) Barluenga, J.; Trincado, M.; Rubio, E.; González, J. M.
Angew. Chem. Int. Ed. 2003, 42, 2406. (j) Yue, D.; Yao, T.;
(7) Sakakura, A.; Ukai, A.; Ishihara, K. Nature 2007, 445, 900.
(8) CCDC 731726 (2m) contains the supplementary
crystallographic data for this paper. This data can be
obtained free of charge from The Cambridge
data_request/cif.
(9) (a) Magdziak, D.; Meek, S. J.; Pettus, T. R. R. Chem. Rev.
2004, 104, 1383. (b) Kürti, L.; Szilágyi, L.; Antus, S.;
Nógrádi, M. Eur. J. Org. Chem. 1999, 2579. (c)Bérubé,A.;
Drutu, I.; Wood, J. L. Org. Lett. 2006, 8, 5421.
(10) (a) Chittimalla, S. K.; Shiao, H.-Y.; Liao, C.-C. Org. Biomol.
Chem. 2006, 4, 2267. (b) Dong, S.; Hamel, E.; Bai, R.;
Covell, D. G.; Beutler, J. A.; Porvo, J. A. Jr. Angew. Chem.
Int. Ed. 2009, 48, 1494.
(11) Okitsu, T.; Iwatsuka, K.; Wada, A. Chem. Commun. 2008,
6330.
Synlett 2010, No. 2, 203–206 © Thieme Stuttgart · New York